Quoin Pharmaceuticals, Ltd. (QNRX)
USD 0.56
(-6.65%)
USD 0.56
(-6.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | -280 Thousand |
| Cost of Revenue | 103.43 Thousand | 103.63 Thousand | 104.11 Thousand | 104.77 Thousand | 227.05 Thousand | 125.72 Thousand |
| Gross Profit | -103.43 Thousand | -103.63 Thousand | -104.11 Thousand | -104.77 Thousand | -227.05 Thousand | -405.72 Thousand |
| Operating Expenses | 9.37 Million | 9.25 Million | 6.06 Million | 1.67 Million | 1.56 Million | 16.22 Million |
| Selling, General and Administrative Expenses | 6.07 Million | 6.58 Million | 4.49 Million | 1.42 Million | 1.51 Million | 7.96 Million |
| Research and Development Expenses | 3.3 Million | 2.67 Million | 1.56 Million | 244.15 Thousand | 45.65 Thousand | 8.25 Million |
| Other Expenses | - | 417.3 Thousand | -14.03 Million | -378.33 Thousand | - | - |
| Cost and Expenses | 9.37 Million | 9.25 Million | 6.06 Million | 1.67 Million | 1.56 Million | 16.22 Million |
| Operating Income | -9.37 Million | -8.84 Million | -20.37 Million | -2.04 Million | -1.56 Million | 15.31 Million |
| Interest Expense | - | 714.08 Thousand | 1.09 Million | 47.02 Thousand | 412.29 Thousand | - |
| Income Tax Expense | - | -104.04 Thousand | -12.94 Million | -331.31 Thousand | 1.55 Million | -161.14 Thousand |
| Earnings before Tax | -8.68 Million | -9.38 Million | -21.46 Million | -2.09 Million | -1.56 Million | 15.31 Million |
| Net Income | -8.68 Million | -9.27 Million | -8.51 Million | -1.76 Million | -1.56 Million | 15.31 Million |
| Earnings Per Share Basic | -9.64 | -22.97 | -322.49 | -88.10 | -440.29 | 7100.73 |
| Earnings Per Share Diluted | -9.64 | -22.97 | -322.49 | -88.10 | -440.29 | 7100.73 |
| Weighted Average Shares Outstanding | 900.91 Thousand | 403.88 Thousand | 26.41 Thousand | 20.02 Thousand | 3544.04 | 2157.10 |
| Weighted Average Shares Outstanding (Diluted) | 900.91 Thousand | 403.88 Thousand | 26.41 Thousand | 20.02 Thousand | 3544.04 | 2157.10 |
| Gross Margin | - | - | - | - | - | 1.45 |
| EBIT Margin | - | - | - | - | - | -54.70 |
| Profit Margin | - | - | - | - | - | -54.70 |
| EBITDA | -9.27 Million | -8.74 Million | -21.37 Million | -2 Million | -1.53 Million | -5.46 Million |
| Earnings Before Tax Margin | - | - | - | - | - | -54.70 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 154.77 Thousand | - | - |
| Cost of Revenue | 24.9 Thousand | 25.27 Thousand | 103.43 Thousand | 25.95 Thousand | 25.91 Thousand | 25.7 Thousand |
| Gross Profit | -24.9 Thousand | -25.27 Thousand | -103.43 Thousand | 128.82 Thousand | -25.91 Thousand | -25.7 Thousand |
| Operating Expenses | 2.1 Million | 2.46 Million | 9.25 Million | 2.21 Million | 2.12 Million | 2.26 Million |
| Selling, General and Administrative Expenses | 1.61 Million | 1.63 Million | - | 1.4 Million | 1.36 Million | 1.63 Million |
| Research and Development Expenses | 492.54 Thousand | 826.9 Thousand | - | 815.46 Thousand | 758.75 Thousand | 625.1 Thousand |
| Other Expenses | - | - | - | 14.04 Thousand | - | -34.47 Thousand |
| Cost and Expenses | 2.12 Million | 2.48 Million | 9.35 Million | 2.24 Million | 2.12 Million | 2.26 Million |
| Operating Income | -2.12 Million | -2.48 Million | -9.35 Million | -2.24 Million | -1.92 Million | -2.1 Million |
| Interest Expense | - | - | - | 218.91 Thousand | - | - |
| Income Tax Expense | 1.96 Million | 2.00 | 8.66 Million | 2.07 Million | -23.89 Thousand | -187.58 Thousand |
| Earnings before Tax | -1.96 Million | -2.35 Million | -8.66 Million | -2.07 Million | -1.92 Million | -2.1 Million |
| Net Income | -1.96 Million | -2.35 Million | -8.66 Million | -2.07 Million | -1.92 Million | -2.1 Million |
| Earnings Per Share Basic | -0.39 | -1.12 | - | -2.10 | -1.95 | -2.13 |
| Earnings Per Share Diluted | -0.39 | -1.12 | - | -2.10 | -1.95 | -2.13 |
| Weighted Average Shares Outstanding | 5.04 Million | 2.1 Million | 900.91 Thousand | 987.22 Thousand | 987.22 Thousand | 987.21 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 5.04 Million | 2.1 Million | 900.91 Thousand | 987.22 Thousand | 987.22 Thousand | 987.21 Thousand |
| Gross Margin | - | - | - | 0.83 | - | - |
| EBIT Margin | - | - | - | -14.32 | - | - |
| Profit Margin | - | - | - | -13.39 | - | - |
| EBITDA | -2.1 Million | -2.46 Million | - | -2.21 Million | -1.92 Million | -2.23 Million |
| Earnings Before Tax Margin | - | - | - | -14.48 | - | - |
BRLXF
2191
015860
HROWL
IMC
FLIDY